oseltamivir phosphate

Generic: oseltamivir phosphate

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oseltamivir phosphate
Generic Name oseltamivir phosphate
Labeler asclemed usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

oseltamivir phosphate 75 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-597
Product ID 76420-597_045b5851-b429-0639-e063-6394a90aa208
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209421
Listing Expiration 2026-12-31
Marketing Start 2018-10-05

Pharmacologic Class

Classes
neuraminidase inhibitor [epc] neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420597
Hyphenated Format 76420-597

Supplemental Identifiers

RxCUI
312122
UNII
4A3O49NGEZ

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oseltamivir phosphate (source: ndc)
Generic Name oseltamivir phosphate (source: ndc)
Application Number ANDA209421 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 10 CAPSULE in 1 BLISTER PACK (76420-597-10)
source: ndc

Packages (1)

Ingredients (1)

oseltamivir phosphate (75 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "045b5851-b429-0639-e063-6394a90aa208", "openfda": {"unii": ["4A3O49NGEZ"], "rxcui": ["312122"], "spl_set_id": ["78f85d27-9935-4775-b8d7-275e11429b76"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 CAPSULE in 1 BLISTER PACK (76420-597-10)", "package_ndc": "76420-597-10", "marketing_start_date": "20230902"}], "brand_name": "Oseltamivir Phosphate", "product_id": "76420-597_045b5851-b429-0639-e063-6394a90aa208", "dosage_form": "CAPSULE", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "76420-597", "generic_name": "Oseltamivir Phosphate", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oseltamivir Phosphate", "active_ingredients": [{"name": "OSELTAMIVIR PHOSPHATE", "strength": "75 mg/1"}], "application_number": "ANDA209421", "marketing_category": "ANDA", "marketing_start_date": "20181005", "listing_expiration_date": "20261231"}